Alzheimers disease. Call your attention to one stock. Those would be the shares of biojin right now up 7 . Up 30 in the past three months at alltime highs now after releasing very encouraging data on an experimental alzheimers drug. Telling us about it at this time yesterday and shes now back with more detail. Hi, meg. Hi tyler. Incredibly High Expectations for this drug leading into today and analysts say biogin met and exceeded them. Shocking investors saying the medicine appeared to slow the cognitive declines associated with alzheimers and today how well the drug appeared to work both on memory loss and clearing of the am lloydoidloyd plaqued that build up in the brain. Next step, find balance between safety and efficacy. Results of early. Doctors are encouraged and important to note the drug was tested in patients at very early stages of alzheimers disease who might benefit if it reach ares the market. Next the Company Moves the drug quickly into a phase three study jumping over t
UBQ Materials Launches World of UBQ Consumer Marketing Campaign, Empowering Consumers to Push for Sustainability in Top Brands tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Best Media Info: This is the first occasion where the company is collectively highlighting the value of its platforms through its films in the country| Ad Craft News